Pilot study: CD40L concentration during ECLS for analysis of platelet functio
- Conditions
- Reduced platelet function during ECLS/ECMO
- Registration Number
- DRKS00028899
- Lead Sponsor
- niversitätsklinikum Gießen und Marburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
ECLS support
Exclusion Criteria
• Additional mechanical circulatory support (CPB, IABP, VAD); Impella are allowed
• Heparin-induced thrombocytopenia Typ II
• less than two measurements possible
• participation is medically not possible
• termination of the whole study
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Concetration of sCD40L and release capacity of CD40
- Secondary Outcome Measures
Name Time Method Thrombopoetin<br>Erythropoetin